Ichiro Kawada

Amplification of EGFR Wild-Type Alleles in Non–Small Cell Lung Cancer Cells Confers Acquired Resistance to Mutation-Selective EGFR Tyrosine Kinase Inhibitors

Shigenari Nukaga, Hiroyuki Yasuda, Katsuya Tsuchihara et al. · Cancer Research · 2017 · 173 citations

<i>In vitro</i> modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant <i>EGFR</i> mutants in non-small-cell lung cancer

Toshiyuki Hirano, Hiroyuki Yasuda, Tetsuo Tani et al. · Oncotarget · 2015 · 157 citations · Full text

Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells

Hideo Watanabe, Kenzo Soejima, Hiroyuki Yasuda et al. · Cancer Cell International · 2008 · 152 citations · Full text

Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial

Masaharu Shinkai, Kenji Tsushima, Shingo Tanaka et al. · Infectious Diseases and Therapy · 2021 · 77 citations · Full text

Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung Cancer

Masayoshi Miyawaki, Hiroyuki Yasuda, Tetsuo Tani et al. · Molecular Cancer Research · 2016 · 71 citations · Full text